Breaking News: The FDA has approved our innovative new treatment for people living with hemophilia B.
CSL has been at the forefront of innovation for bleeding disorders for 35+ years. Hear from our CEO, Paul Perreault, on this milestone.
Learn more: https://bit.ly/3i1j1DY
CSL has been at the forefront of innovation for bleeding disorders for 35+ years. Hear from our CEO, Paul Perreault, on this milestone.
Learn more: https://bit.ly/3i1j1DY